Stockscreener 앱 받기
12.13
1.94%
-0.24
시간 외 거래:
12.12
-0.01
-0.08%
전일 마감가:
$12.37
열려 있는:
$12.38
하루 거래량:
157.62K
Relative Volume:
1.23
시가총액:
$345.44M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.46%
1개월 성능:
+5.66%
6개월 성능:
-17.71%
1년 성능:
-12.67%
1일 변동 폭
$12.09
$12.40
1주일 범위
$11.88
$12.53
52주 변동 폭
$10.55
$15.90
Abrdn Life Sciences Investors Stock (HQL) Company Profile
HQL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
12.13 | 345.44M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.65 | 3.56B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
33.82 | 2.97B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
25.25 | 2.47B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
20.10 | 2.26B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
14.68 | 2.22B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors 주식(HQL)의 최신 뉴스
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Stock Price Up 3% – What’s Next? - Defense World
abrdn Healthcare Investors (HQH) Sets $0.54 Monthly Dividend - GuruFocus
HQL Declares $0.43 Monthly Dividend Yielding 41.92% - GuruFocus
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Grows By 46.5% - MarketBeat
AQR Arbitrage LLC Has $2.47 Million Stake in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 26.2% in April - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Shares Sold by AQR Arbitrage LLC - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Stock Position Increased by Invesco Ltd. - Defense World
Raymond James Financial Inc. Invests $3.13 Million in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Quarry LP - MarketBeat
Quarry LP Lowers Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount - Yahoo
Walleye Capital LLC Invests $477,000 in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update - ACCESS Newswire
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Increases By 26.3% - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 9,144 Shares - MarketBeat
937,656 Shares in Abrdn Healthcare Investors (NYSE:HQH) Purchased by Raymond James Financial Inc. - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Down 26.0% in March - MarketBeat
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Short Interest Update - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $179,718.00 in Stock - MarketBeat
Saba Capital Management, L.P. Sells 30,156 Shares of Abrdn Life Sciences Investors (NYSE:HQL) Stock - MarketBeat
1607 Capital Partners LLC Sells 102,354 Shares of Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Declines By 26.0% - Defense World
Saba capital management sells $179,718 in Abrdn life sciences stock - Investing.com Australia
Series CGlycomine - Crunchbase
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG - Business Wire
LPL Financial LLC Has $3.77 Million Holdings in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock - Investing.com Australia
Wilson Sonsini Advises Glycomine on $115 Million Series C - Wilson Sonsini
Saba capital management sells $179,718 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
LPL Financial LLC Raises Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock By Investing.com - Investing.com South Africa
Abrdn Life Sciences Investors (HQL) 재무 분석
Abrdn Life Sciences Investors (HQL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.17%
자본화:
|
볼륨(24시간):